Developer docs
API playgroundTry for free, no card

Search company profiles

PerioTrap Pharmaceuticals GmbH

Full company profile

uuid0003f4f

Namestring
PerioTrap Pharmaceuticals GmbH
Legal namestring
PerioTrap Pharmaceuticals GmbH
Websiteurl
periotrap.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

PerioTrap Pharmaceuticals GmbH is a German biopharmaceutical company founded in 2018 as a spin-off from the Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI), headquartered in Halle (Saale) at the Weinberg Campus technology park. The company develops a patented selective pathoblocker technology that targets the virulence mechanisms of periodontal pathogens — specifically Porphyromonas gingivalis via the small molecule S-0636 — without killing beneficial oral bacteria, thereby preserving the oral microbiome. This mechanistic approach is differentiated from conventional broad-spectrum antibacterial oral care products such as chlorhexidine, and is supported by multiple peer-reviewed publications and an endorsement from the German Society of Periodontology (DG PARO).

The company's commercial portfolio comprises two core products unified by the underlying PerioTrap® technology: a consumer-facing Mikrobiom Zahnpasta (microbiome toothpaste) priced at €14.95 per unit and sold direct-to-consumer via a Shopify e-commerce storefront, and a professional Prophylaxe Pflege-Gel (prophylaxis care gel) distributed to dental practices through Henry Schein and direct sales channels. A sonic toothbrush (Eco Vibe 3) is offered as a complementary accessory. The company serves two primary customer segments: health-conscious consumers seeking microbiome-friendly daily oral care, and dental professionals seeking adjunctive prophylaxis solutions for periodontal treatment.

PerioTrap employs a hybrid go-to-market model combining DTC e-commerce, B2B distribution via Henry Schein, and pharmacy/dental depot partnerships across Germany, Austria, and Switzerland. The company has raised approximately €5.8M cumulatively across seed (€200K, 2021), crowd-investing (€2.7M, 2025), and Pre-Series A first tranche (€2.9M, 2026) rounds. Operational team consists of fewer than 10 employees including microbiologists, pharmacists, and dentists. The microbiome toothpaste launch in 2026 achieved a complete sell-out within 12 hours of German media coverage, and the company is currently managing demand via a production waitlist while pursuing international expansion.

Short descriptiontext

PerioTrap Pharmaceuticals GmbH is a German biotech spin-off from Fraunhofer IZI that develops a patented selective pathoblocker technology targeting Porphyromonas gingivalis virulence to treat periodontitis, selling microbiome-friendly consumer toothpaste via DTC e-commerce and a professional prophylaxis gel to dental practices through Henry Schein distribution.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHaale, Germany
HQ citystring
Haale
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oral care products, microbiome toothpaste, periodontal therapeutics, dental prophylaxis gel, pathoblocker molecules
Industry2 codes
1Microbiome Modulating Small Molecules & Antibiotic Alternatives
CodeHLAAAFAGPrimaryYes
2Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening)
CodeCRADAMAAPrimaryNo
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Toilet Preparation Manufacturing325620
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Oral Care Pharmaceuticals
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Consumer Oral Care Products
TypeOne Time License
Description

Direct-to-consumer sales of PerioTrap microbiome toothpaste (€14.95 per unit) through the company's Shopify e-commerce platform. Also sells sonic toothbrushes and other oral care accessories.

periotrap.com
2Professional Dental Products
TypeOne Time License
Description

B2B sales of Prophylaxe Pflege-Gel (prophylaxis care gel) to dental practices through Henry Schein distribution network and direct sales to dental professionals for use in clinical settings.

periotrap.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Pricing details2 tiers
1PerioTrap Mikrobiom Zahnpasta - Consumer toothpaste
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€14.95 per unit (€19.93 per 100ml). Currently in production with waitlist for availability.

periotrap.com
2Schallzahnbürste Eco Vibe 3 - Sonic toothbrush accessory
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€69.98 per unit (sold as a set).

periotrap.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1PerioTrap®
Description

The company's core brand for oral microbiome-friendly dental care products including toothpaste and prophylaxis care gel.

periotrap.com
Core offering1 text field

PerioTrap develops and commercializes microbiome-friendly oral care products that selectively block the virulence mechanisms of pathogenic bacteria (notably Porphyromonas gingivalis) responsible for periodontitis while preserving the healthy oral microbiome. Its commercial portfolio includes a daily-use consumer toothpaste (Mikrobiom Zahnpasta) and a professional dental prophylaxis gel (Prophylaxe Pflege-Gel), both built on its patented PerioTrap® pathoblocker technology developed over more than 10 years at Fraunhofer IZI.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduces harmful biofilm mass by up to 25%
+3 more records
Product overview1 text field

PerioTrap Pharmaceuticals GmbH offers a dual-portfolio product strategy targeting both consumers and dental professionals, unified by the company's patented PerioTrap® technology. The consumer-facing portfolio centers on the PerioTrap® Mikrobiom Zahnpasta, a daily-use microbiome-friendly toothpaste that selectively blocks periodontal pathogens (notably Porphyromonas gingivalis) without damaging beneficial oral bacteria. The professional portfolio includes the PerioTrap® Prophylaxe Pflege-Gel, a dental-prophylaxis gel for use in clinical practice, complementing the consumer toothpaste as part of a system-care approach ("Systempflege: Professionell begleitet, präventiv gedacht"). Both products are grounded in over 10 years of research from the Fraunhofer IZI spin-off and are manufactured in Germany. The company also retails a sonic toothbrush (Eco Vibe 3) as a complementary accessory.

Product and service3 records
1PerioTrap® Mikrobiom Zahnpasta (Oral Microbiome Toothpaste)
CategoryConsumer Oral Care
Description

A microbiome-friendly toothpaste for daily home use that selectively blocks the virulence mechanisms of periodontal pathogens such as Porphyromonas gingivalis while preserving the healthy oral microbiome. Priced at €14.95 per unit (€19.93 per 100ml), sold direct-to-consumer and through professional channels.

2PerioTrap® Prophylaxe Pflege-Gel (Prophylaxis Care Gel)
CategoryProfessional Dental Care
Description

A prophylaxis care gel for professional dental use that supports tissue regeneration, soothes tissue, and complements periodontal prophylaxis treatment for patients with gingival or periodontal risk. Uses the same selective PerioTrap® technology as the consumer toothpaste. Distributed via Henry Schein and direct sales to dental professionals.

3Schallzahnbürste Eco Vibe 3 Set S (Sonic Toothbrush Eco Vibe 3)
CategoryOral Care Accessory
Description

A sonic toothbrush sold as a bundled accessory set alongside PerioTrap oral care products, priced at €69.98 per set, marketed as a complement to daily oral hygiene routines for consumers.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Fraunhofer Institute for Cell Therapy and Immunology, from which PerioTrap spun off. The company was founded based on research conducted at Fraunhofer IZI, with founding scientists continuing research relationships.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

One of the largest dental product distributors globally, now distributing PerioTrap Prophylaxe Pflege-Gel and Mikrobiom Zahnpasta to dental practices in Germany through their established procurement and ordering systems.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Partner for the GBT Summit 2026 in Berlin, where PerioTrap exhibited alongside EMS Dental to promote modern prevention-oriented concepts and innovative solutions for successful dental practice management.

4Fly Fulfillment GmbH
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Logistics and fulfillment service provider handling warehousing and shipping of PerioTrap products, using JTL-Fulfillment Network for operational management. Delivers via DPD and DHL.

periotrap.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PerioTrap Pharmaceuticals GmbH

Oral Care Pharmaceuticalsperiotrap.com

PerioTrap Pharmaceuticals GmbH is a German biotech spin-off from Fraunhofer IZI that develops a patented selective pathoblocker technology targeting Porphyromonas gingivalis virulence to treat periodontitis, selling microbiome-friendly consumer toothpaste via DTC e-commerce and a professional prophylaxis gel to dental practices through Henry Schein distribution.

What PerioTrap Pharmaceuticals GmbH does

PerioTrap Pharmaceuticals GmbH is a German biopharmaceutical company founded in 2018 as a spin-off from the Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI), headquartered in Halle (Saale) at the Weinberg Campus technology park. The company develops a patented selective pathoblocker technology that targets the virulence mechanisms of periodontal pathogens — specifically Porphyromonas gingivalis via the small molecule S-0636 — without killing beneficial oral bacteria, thereby preserving the oral microbiome. This mechanistic approach is differentiated from conventional broad-spectrum antibacterial oral care products such as chlorhexidine, and is supported by multiple peer-reviewed publications and an endorsement from the German Society of Periodontology (DG PARO).

The company's commercial portfolio comprises two core products unified by the underlying PerioTrap® technology: a consumer-facing Mikrobiom Zahnpasta (microbiome toothpaste) priced at €14.95 per unit and sold direct-to-consumer via a Shopify e-commerce storefront, and a professional Prophylaxe Pflege-Gel (prophylaxis care gel) distributed to dental practices through Henry Schein and direct sales channels. A sonic toothbrush (Eco Vibe 3) is offered as a complementary accessory. The company serves two primary customer segments: health-conscious consumers seeking microbiome-friendly daily oral care, and dental professionals seeking adjunctive prophylaxis solutions for periodontal treatment.

PerioTrap employs a hybrid go-to-market model combining DTC e-commerce, B2B distribution via Henry Schein, and pharmacy/dental depot partnerships across Germany, Austria, and Switzerland. The company has raised approximately €5.8M cumulatively across seed (€200K, 2021), crowd-investing (€2.7M, 2025), and Pre-Series A first tranche (€2.9M, 2026) rounds. Operational team consists of fewer than 10 employees including microbiologists, pharmacists, and dentists. The microbiome toothpaste launch in 2026 achieved a complete sell-out within 12 hours of German media coverage, and the company is currently managing demand via a production waitlist while pursuing international expansion.

PerioTrap Pharmaceuticals GmbH firmographics

Firmographics
Name
PerioTrap Pharmaceuticals GmbH
Legal name
PerioTrap Pharmaceuticals GmbH
Website
https://periotrap.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
1–10 employees
Short description
PerioTrap Pharmaceuticals GmbH is a German biotech spin-off from Fraunhofer IZI that develops a patented selective pathoblocker technology targeting Porphyromonas gingivalis virulence to treat periodontitis, selling microbiome-friendly consumer toothpaste via DTC e-commerce and a professional prophylaxis gel to dental practices through Henry Schein distribution.
Ownership category
akta.pro rank

PerioTrap Pharmaceuticals GmbH industry classification

Industry
Product category
Oral Care Pharmaceuticals
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Toilet Preparation Manufacturing (325620)
SIC
Biological Products, (No Disgnostic Substances) (2836), Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro primary industry
Microbiome Modulating Small Molecules & Antibiotic Alternatives (HLAAAFAG)
akta.pro secondary industry
Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening) (CRADAMAA)

Keywords

  • Oral care products
  • Microbiome toothpaste
  • Periodontal therapeutics
  • Dental prophylaxis gel
  • Pathoblocker molecules

Where PerioTrap Pharmaceuticals GmbH is headquartered

Location

Headquarters

HQ city
Haale
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

PerioTrap Pharmaceuticals GmbH business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Consumer Oral Care Products: Direct-to-consumer sales of PerioTrap microbiome toothpaste (€14.95 per unit) through the company's Shopify e-commerce platform. Also sells sonic toothbrushes and other oral care accessories.
  2. Professional Dental Products: B2B sales of Prophylaxe Pflege-Gel (prophylaxis care gel) to dental practices through Henry Schein distribution network and direct sales to dental professionals for use in clinical settings.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPerioTrap Mikrobiom Zahnpasta - Consumer toothpaste
Unit PricingPay-as-you-goSchallzahnbürste Eco Vibe 3 - Sonic toothbrush accessory

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

PerioTrap Pharmaceuticals GmbH product offering

Product offering

Core offering

PerioTrap develops and commercializes microbiome-friendly oral care products that selectively block the virulence mechanisms of pathogenic bacteria (notably Porphyromonas gingivalis) responsible for periodontitis while preserving the healthy oral microbiome. Its commercial portfolio includes a daily-use consumer toothpaste (Mikrobiom Zahnpasta) and a professional dental prophylaxis gel (Prophylaxe Pflege-Gel), both built on its patented PerioTrap® pathoblocker technology developed over more than 10 years at Fraunhofer IZI.

Product overview

PerioTrap Pharmaceuticals GmbH offers a dual-portfolio product strategy targeting both consumers and dental professionals, unified by the company's patented PerioTrap® technology. The consumer-facing portfolio centers on the PerioTrap® Mikrobiom Zahnpasta, a daily-use microbiome-friendly toothpaste that selectively blocks periodontal pathogens (notably Porphyromonas gingivalis) without damaging beneficial oral bacteria. The professional portfolio includes the PerioTrap® Prophylaxe Pflege-Gel, a dental-prophylaxis gel for use in clinical practice, complementing the consumer toothpaste as part of a system-care approach ("Systempflege: Professionell begleitet, präventiv gedacht"). Both products are grounded in over 10 years of research from the Fraunhofer IZI spin-off and are manufactured in Germany. The company also retails a sonic toothbrush (Eco Vibe 3) as a complementary accessory.

Differentiator

Problem solved

Functional benefit

Brands

  • PerioTrap®: The company's core brand for oral microbiome-friendly dental care products including toothpaste and prophylaxis care gel.

Products and services

  • PerioTrap® Mikrobiom Zahnpasta (Oral Microbiome Toothpaste) A microbiome-friendly toothpaste for daily home use that selectively blocks the virulence mechanisms of periodontal pathogens such as Porphyromonas gingivalis while preserving the healthy oral microbiome. Priced at €14.95 per unit (€19.93 per 100ml), sold direct-to-consumer and through professional channels.
  • PerioTrap® Prophylaxe Pflege-Gel (Prophylaxis Care Gel) A prophylaxis care gel for professional dental use that supports tissue regeneration, soothes tissue, and complements periodontal prophylaxis treatment for patients with gingival or periodontal risk. Uses the same selective PerioTrap® technology as the consumer toothpaste. Distributed via Henry Schein and direct sales to dental professionals.
  • Schallzahnbürste Eco Vibe 3 Set S (Sonic Toothbrush Eco Vibe 3) A sonic toothbrush sold as a bundled accessory set alongside PerioTrap oral care products, priced at €69.98 per set, marketed as a complement to daily oral hygiene routines for consumers.

Quantifiable outcome

  • Reduces harmful biofilm mass by up to 25%
  • +3 more outcomes

Companies that use PerioTrap Pharmaceuticals GmbH

Customer profile

Named customers3 records

Segments2 records

Ideal customer profiles2 records

PerioTrap Pharmaceuticals GmbH technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

PerioTrap Pharmaceuticals GmbH partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Fraunhofer IZIcoreStrategic or Co-development PartnerFraunhofer Institute for Cell Therapy and Immunology, from which PerioTrap spun off. The company was founded based on research conducted at Fraunhofer IZI, with founding scientists continuing research relationships.
  • Henry ScheincoreChannel Partner/ Reseller/ DistributorOne of the largest dental product distributors globally, now distributing PerioTrap Prophylaxe Pflege-Gel and Mikrobiom Zahnpasta to dental practices in Germany through their established procurement and ordering systems.
  • EMS Dental DeutschlandminorGTM or Marketing PartnerPartner for the GBT Summit 2026 in Berlin, where PerioTrap exhibited alongside EMS Dental to promote modern prevention-oriented concepts and innovative solutions for successful dental practice management.
  • Fly Fulfillment GmbHminorImplementation/ SI/ Consulting PartnerLogistics and fulfillment service provider handling warehousing and shipping of PerioTrap products, using JTL-Fulfillment Network for operational management. Delivers via DPD and DHL.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

PerioTrap Pharmaceuticals GmbH competitors and assessment

Company assessment

Market position

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

PerioTrap Pharmaceuticals GmbH social profiles

Digital presence

PerioTrap Pharmaceuticals GmbH financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PerioTrap Pharmaceuticals GmbH leadership team

Management profile

Number of profiles

Profiles11 records

PerioTrap Pharmaceuticals GmbH funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PerioTrap Pharmaceuticals GmbH M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PerioTrap Pharmaceuticals GmbH

What does PerioTrap Pharmaceuticals GmbH do?

PerioTrap develops and commercializes microbiome-friendly oral care products that selectively block the virulence mechanisms of pathogenic bacteria (notably Porphyromonas gingivalis) responsible for periodontitis while preserving the healthy oral microbiome. Its commercial portfolio includes a daily-use consumer toothpaste (Mikrobiom Zahnpasta) and a professional dental prophylaxis gel (Prophylaxe Pflege-Gel), both built on its patented PerioTrap® pathoblocker technology developed over more than 10 years at Fraunhofer IZI.

Is PerioTrap Pharmaceuticals GmbH a public or private company?

PerioTrap Pharmaceuticals GmbH is a private company. It is classified as venture growth investor backed and is currently operating.

When was PerioTrap Pharmaceuticals GmbH founded?

PerioTrap Pharmaceuticals GmbH was founded in 2018. It employs 1 to 10 people.

Where is PerioTrap Pharmaceuticals GmbH based?

PerioTrap Pharmaceuticals GmbH is headquartered in Haale, Germany, in the Europe region.

How does PerioTrap Pharmaceuticals GmbH make money?

Two revenue lines are on record. Consumer Oral Care Products are the primary driver. The others are professional Dental Products.

Does PerioTrap Pharmaceuticals GmbH have an API?

No public API is recorded for PerioTrap Pharmaceuticals GmbH.

What industry is PerioTrap Pharmaceuticals GmbH in?

PerioTrap Pharmaceuticals GmbH's product category is Oral Care Pharmaceuticals. Its primary akta.pro industry code is HLAAAFAG, Microbiome Modulating Small Molecules & Antibiotic Alternatives, with a secondary code of CRADAMAA, Oral Care Products (Toothpaste, Mouthwash, Dental Floss, Whitening). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Startbase2.9 million euros for Fraunhofer spin-off PerioTrapPerioTrap, a BioTech start-up spin-off from Fraunhofer-Gesellschaft based in Halle (Saale), has secured 2.9 million euros in the first tranche of its Pre-Series A financing round, with investments from the business angel network Companisto and venture capital firm bmp Ventures. The company is developing a novel periodontitis treatment using a selective active ingredient that targets harmful bacteria while preserving the healthy oral microbiome. The financing round will remain open until May 2026 as the start-up continues to receive investment requests following strong media coverage that sold out its microbiome toothpaste within twelve hours.Technologiepark-Weinberg-CampusPerioTrap sichert sich 2,7 Millionen EuroPerioTrap Pharmaceuticals, a biotech startup based at Weinberg Campus, completed a funding round of 2.7 million euros, exceeding its crowd-investing goal with over one million euros from nearly 700 private investors. The company plans to advance the market entry of a new gel and toothpaste to combat periodontal disease.SeznamzpravyČeši investují do německého výzkumu paradentózy 200 tisíc eurCzech biotechnology incubator i&i Prague invested 200,000 euros into German start-up PerioTrap Pharmaceuticals to support research on a new antibiotic for periodontitis. This marks the first time i&i Prague has invested outside the Czech Republic, aiming to foster international cooperation and back high-quality technology. The funding contributes to a total of three million euros raised by PerioTrap for developing treatments that target harmful oral bacteria.InipraguePeriotrap seed roundPerioTrap Pharmaceuticals secured seed funding from bmp Ventures AG, IBG-Fonds, i&i Prague, and Fraunhofer Venture to advance its novel treatment for periodontitis. The investment will support the optimization of its lead compound and progress the prolonged-release pharmaceutical composition through clinical testing and market approval processes.